The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
The NMDA Receptor, NMDA Antagonists and Epilepsy Therapy: A Status Report
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular cloning and characterization of the rat NMDA receptor
Moriyoshi, K., Masu, M., Ishii, T., Shigemoto, R., Mizuno, N., & Nakanishi, S. (1991) · Nature · doi:10.1038/354031a0 · Cited by 1,771
Cited by
Human EEG gamma oscillations in neuropsychiatric disorders
Herrmann, C. S., & Demiralp, T. (2005) · Clinical Neurophysiology · doi:10.1016/j.clinph.2005.07.007 · Cited by 599
Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites
Moroni, F. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00196-x · Cited by 346
Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines
Rogawski, M. A. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90005-5 · Cited by 313
Self-citationParsons, C. G., Quack, G., Bresink, I., Baran, L., Przegalinski, E., Kostowski, W., Krzascik, P., Hartmann, S., & Danysz, W. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00092-k · Cited by 311
Lamotrigine: A Review of its Pharmacological Properties and Clinical Efficacy in Epilepsy
Goa, K. L., Ross, S. R., & Chrisp, P. (1993) · Drugs · doi:10.2165/00003495-199346010-00009 · Cited by 307
Metadata
- Authors
- Rogawski, M. A.
- Venue
- Drugs
- Published
- 1992-09
- Volume
- 44
- Issue
- 3
- Pages
- 279-292
- ISSN
- 0012-6667 (ISSN-L)
- OpenAlex
- W2071529758
- Cited by
- 165
- References
- 1
- FWCI
- 13.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The NMDA Receptor, NMDA Antagonists and Epilepsy Therapy: A Status Report. https://app.cochat.ai/papers/10.2165/00003495-199244030-00001
- The paper
- Rogawski, M. A. (1992). The NMDA Receptor, NMDA Antagonists and Epilepsy Therapy: A Status Report. Drugs. https://doi.org/10.2165/00003495-199244030-00001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.